Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

See How to

Filter conferences

Synthetic Biology-Based Therapies Summit 2022

Synthetic Biology-Based Therapies Summit 2022


Date of beginning

Tuesday, 13 December 2022


3 days




United States


Rosie Andre


This email address is being protected from spambots. You need JavaScript enabled to view it.


Over the past couple of years, the engineered biology market has seen fledgling companies rise to IPO smashing power players, as the demand for high-quality, engineered biomolecules and controllable therapeutics grows exponentially. The therapeutic potential of novel synthetic units is huge, but challenges remain in demonstrating proof-of-concept, developing assays, functional characterization, manufacturing scale-up, and identifying therapeutic applications for commercial development. Returning for the 2nd year, the Synthetic Biology-Based Therapies Summit is the industry-defining forum made exclusively for leaders in the synthetic and engineered biology space, focusing on the technical challenges that lie ahead in the path towards commercialization. Learn from industry trailblazers at Arsenal Biosciences,, MIT, Novome Bio, Strand Therapeutics, Synlogic and more, to support your efforts in developing safe and effective synthetic biology-based therapeutics. Tickets Prices:Conference + Workshop Day - Industry Pricing USD 3497.00Conference Only - Industry Pricing USD 2599.00Conference + Workshop Day - Service Provider Pricing USD 4297.00Conference Only - Service Provider Pricing USD 3199.00Conference + Workshop Day - Academic Pricing USD 2897.00Conference Only - Academic Pricing USD 2199.00 Speakers: Matt Drever, Vice President, Molecular Biology & Protein Engineering, Arsenal Biosciences, Andrew Phillips, Director, Bioinformatics & Biologics Engineering, AstraZeneca, Mark Kotter, Founder & Chief Executive Officer,, Edward Green, Founder & Chief Scientific Advisor, CHAIN Biotechnology, Adam Silverman, Senior Director, Therapeutic Discovery, Codexis, Marc Güell, Co-Founder & Scientific Lead, Integra Therapeutics, Qi Cai, Director, Cell Biology, Kite Pharma: A Gilead Company, Wenning Qin, Senior Vice President, Research, eGenesis Inc., Héctor Garcia Martin, Staff Scientist, Lawrence Berkeley National Laboratory, Lee Cooper, Senior Director, Venture Investments, Leaps by Bayer, Michael Hudson, Director, Synthetic Biology, LifeMine Therapeutics, Ron Weiss, Professor, Massachusetts Institute of Technology, Grant Murphy, Executive Director, Discovery Biologics, Merck & Co., Lauren Popov, Director, Translational Biology, Novome Biotechnologies, Samuel Schaffter, Bioengineer, National Institute of Standards & Technology, Tariq Warsi, Head of Technical Operations, Novome Biotechnologies, Jaspreet Khurana, Director, Platform & Discovery, Strand Therapeutics, Jonathan Winkler, Senior Director, Analytical Development, Seres Therapeutics, Russell Gordley, Senior Director, Gene Circuit Discovery, Senti Biosciences, Yu Qiu, Digital Biologics Advanced Application Lead, Sanofi, Anders Lund, Head of Analytical Development, Synlogic, Dave Hava, Chief Scientific Officer, Synlogic, David James, Chief Scientific Officer, SynGenSys, Jake Becraft, Co-Founder & Chief Executive Officer, Strand Therapeutics, Maria Soloveychik, Co-Founder & Chief Executive Officer, SyntheX, Ruben Vasquez-Uribe, Co-Principal Investigator of the Bacterial Synthetic Biology Section, The Novo Nordisk Foundation Center for Biosustainability, Stuart Licht, Scientific Director, Protein Science, Moderna, Synthego Representative, Synthego Dates and Time: Starts: Tue, Dec 13, 2022 ( 9:00 AM) and Ends: Thu, Dec 15, 2022 ( 5:00 PM) Venue details: Embassy Suites by Hilton Boston at Logan Airport, 207 Porter Street, Boston, Massachusetts, 02128, United States